| Prev Close | 414.44 |
| Open | 406.50 |
| Day Low/High | 375.10 / 418.31 |
| 52 Wk Low/High | 28.00 / 131.00 |
| Volume | 7.31M |
| Avg Volume | 1.76M |
BioNTech SE (BNTX)
407.47
7.00
1.70
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 228.60M |
| Market Cap | 15.85B |
| EPS | -0.90 |
| Div & Yield | N.A. (N.A) |
Latest News
One Really Bad Dream (or Was It?), Biden Hops on the Rails, Vaccine Booster
Plus, China's central bank plans to cut its Reserve Ratio Requirement and Wells Fargo looks to exit a business line.
Organized Chaos, Growth Concerns, COVID Variant, Trading Amazon and Microsoft
Contrary to popular belief, this economic recovery that we seem to be enjoying has hit a pressure point.
Uncertain Fiscal Policy, FOMC, Virus X Factor, Copper, United Rentals Stock
There's a split growing at the FOMC as to just how transitory the current burst of consumer level inflation actually is.
CureVac Is Down But Not Out: Here's How to Trade It
CVAC is now working on a 'next generation' COVID-19 vaccine candidate with GlaxoSmithKline.
If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It
I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.
Meme Focus, CPI, My Message to the Fed, Gensler to the Rescue? Likes/Dislikes
How long have we cried out in the wilderness with no one listening? Finally, perhaps, a champion has risen from the depths.
Are Chinese Shares Set for a Bull Run?
Last year's top-performing stock market worldwide has been a disappointment since setting an all-time high in February. Could it have just turned?
Jim Cramer: Disbelief in Science vs. COVID Shares Blame for Supply Shortages
We've been caught with our pants down, largely because we had no faith in the smartest people in the country.
A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care
The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.
In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment
ARCT's IP is incredibly valuable, and may in fact be invaluable.
Thursday's Close Shave, Troubling New Highs and Lows, Peloton Kicks Into Gear
The market came within whiskers of a technical breakdown on Thursday, yet few people seem to know or care.
ARKK Under Pressure, Peloton, Vaccine Moral Dilemma, Charting the Nasdaq
The fund is at a key spot technically, and there is real fear that if this spot cracks, what looks like a stretch of rough rapids could become a waterfall.
Invest in Pfizer? Know That the Stock Is Not Volatile or That Risky
PFE reported Q1 earnings Tuesday and handily beat expectations.
Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?
UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
Asian Stocks Falter as Vaccine Programs Stumble
Markets in Tokyo, Mumbai and most of Southeast Asia are down this month, Asia's early progress in combatting COVID-19 proving hard to sustain.
I'm Not Bailing on Johnson & Johnson Now
Don't forget, this is a very large company with a lot more than the vaccine going on.
I'm Buying Arcturus Therapeutics Stock and Here's the Reason Why
My COVID vaccine eligibility actually began about a week before my symptoms began.
Deceptive Monday, Archegos Fallout, 'Impending Doom,' Trading Kratos Defense
The main story unfolded along with the passing hours on Monday, and continues. The ending of this tale perhaps remains far from untold.
Have I Been Given a Dodgy Pfizer Shot in Hong Kong?
Lies, damn lies, and statistics in the vaccine age, as Hong Kong and Macau stop administering the Pfizer/BioNTech drug.
Should You Buy AstraZeneca After Its Positive Vaccine News?
Here's my view on this space and where the money is to be made.
Jim Cramer: Whenever You Think the End Is Near, Think Again
Let's look back at how the market reacted to COVID-19 one year ago, and the lessons we can learn.
Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD
COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?
Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia
The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.
Rounding Action, Hot Retail Sales, Vaccine Thoughts, Trading Twilio and Apple
The funny thing about flat lines is that the move at the end is usually explosive, but could go either way.
There's No Reason to Give Up on Pfizer
Why? Consistency.
Assessing AstraZeneca in the Fight Against the Virus
While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.
Markets This Week, Cyber-Espionage, Stimulus at Hand, 'New' Covid Strain
Are traders working this holiday shortened week? You bet they are.
